Global beauty company selling owned mass cosmetics brands and licensed prestige fragrances for department and drug stores.
Global beauty company selling owned mass cosmetics brands and licensed prestige fragrances for department and drug stores.
Prestige fragrances carry the business: Coty pays licence fees to fashion houses such as Hugo Boss, Calvin Klein and Burberry for the right to make and sell their scents, then sells through department stores, perfumeries and travel retail. Mass cosmetics brands sell through drugstores and discount chains. JAB Holding, a European investment firm, is the controlling shareholder.
Moat: narrow (brand, distribution, scale). Large licensed prestige fragrance portfolio and global distribution scale versus smaller beauty players.
Headquarters: London, United Kingdom · Founded: 1904 · Employees: 11,335
Size Coty (COTY) is a United States Consumer Staples company (Household/Personal Care) with a market value of $3.71B, the 1386th largest of 3,085 United States companies the cockpit tracks. Shares closed at $4.21 on 18 Nov 2026.
Performance Over six months the shares gained 115.9%, against -2.0% for the median peer and -2.2% for the United States market (cap-weighted) — 2nd highest of 21 in its peer set.
Growth Revenue fell 0.2% over the last twelve months (peer median +4.3%); the operating margin is 5.4% (peer median 12.3%).
Valuation It trades at 13.5× forward earnings against a peer median of 23.1× (4th cheapest of 20).
Price implies For today's price to make sense, revenue must grow about 10% a year for seven years (Req g). Recent delivered growth is +5%, so the hurdle is +5 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.
Capital Return on invested capital runs 3.7 points below its cost of capital (7.5% WACC).
Credit Coty has 2 bonds outstanding ($1.30B), rated BB+ by the agencies and trading like BB at a weighted spread of 194 bp.
Short interest Short interest is 4.5% of the free float (30 Oct 2026).
Next results Next results expected around 9 Feb 2027 (exchange calendar; dates can move).
| TTM | FY2026 | FY2025 | FY2024 | FY2023 | |
|---|---|---|---|---|---|
| Revenue | $5.78B | $5.81B | $5.89B | $6.12B | $5.55B |
| Revenue growth | — | -1% | -4% | +10% | — |
| Gross profit | $3.37B | $3.40B | $3.63B | $3.75B | $3.36B |
| EBITDA | $789M | $804M | $949M | $1.01B | $971M |
| Net income | -$563M | -$605M | -$368M | $89.4M | $508M |
| Free cash flow | $422M | $348M | $278M | $369M | $403M |
| Capital expenditure | $181M | $190M | $215M | $245M | $223M |
| Total debt | $3.14B | $3.44B | $4.39B | $4.26B | $4.69B |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
| Company | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g |
|---|---|---|---|---|---|---|
| Coty COTY | $3.71B | +116% | 0% | 5% | 13.5× | 9.8% |
| L'Oreal OR.PA | $259B | +20% | +3% | 21% | 32.3× | 18.1% |
| Estée Lauder Companies (The) EL | $37.7B | +34% | +6% | 13% | 29.4× | 16.2% |
| Interparfums IPAR | $4.28B | +48% | +3% | 18% | 28.4× | 10.5% |
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | COTY | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | +30.8% | +0.9% | highest of 21 |
| 6-month return | +115.9% | -2.0% | 2nd highest of 21 |
| Distance from 52-week high | -3.5% | -21.6% | 3rd highest of 21 |
| Revenue growth (TTM) | -0.2% | +4.3% | 6th lowest of 21 |
| Operating margin | 5.4% | 12.3% | 4th lowest of 21 |
| Forward P/E | 13.5× | 23.1× | 4th cheapest of 20 |
| Growth the price implies (Req g, 7 yrs) | 9.8% | 2.2% | 6th most demanding of 17 |
| Growth delivered (Del g) | +4.6% | +6.0% | 9th highest of 17 |
| Hurdle (Req g minus delivered) | +5.2 pp | -2.6 pp | 4th most demanding of 17 |
| ROIC minus cost of capital | -3.7 pp | +4.7 pp | 2nd lowest of 19 |
| EV / EBITDA | 8.7× | 12.1× | 4th cheapest of 17 |
| Net debt / EBITDA | 3.7× | -0.8× | most indebted of 19 |
| Bond spread | 194 bp | n/a | — |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Coty COTY | United States | $3.71B | +116% | 0% | 5% | 13.5× | 9.8% | +4.6% |
| Lion 4912.T | Japan | $3.85B | +44% | +6% | 8% | 24.3× | 0.9% | +3.5% |
| Rohto Pharmaceutical 4527.T | Japan | $3.87B | +8% | +7% | 12% | 16.5× | -2.8% | +13.7% |
| Interparfums ITP.PA | France | $3.49B | +66% | -4% | 18% | 26.9× | 15.6% | +19.6% |
| Hengan Int'l 1044.HK | Hong Kong | $3.27B | -12% | +2% | 11% | 9.1× | -8.2% | -0.1% |
| Kobayashi Pharmaceutical 4967.T | Japan | $3.25B | +20% | +2% | 6% | 48.7× | 18.0% | +1.9% |
| Mao Geping Cosmetics 1318.HK | Hong Kong | $4.67B | -8% | +32% | 31% | 14.3× | 4.1% | +41.1% |
| Proya Cosmetics 603605.SS | China | $2.87B | -13% | +2% | 13% | 10.9× | -5.3% | +23.1% |
| LG H&h 051900.KS | South Korea | $2.81B | -14% | -3% | 3% | 23.1× | -4.6% | -4.1% |
| Colgate-Palmolive (India) COLPAL.NS | India | $4.91B | -23% | +9% | 28% | 32.4× | 31.1% | +4.5% |
| Cupid CUPID.NS | India | $5.22B | +218% | +125% | 33% | n/a | n/a | n/a |
| Reynolds Consumer Products REYN | United States | $5.28B | +15% | +2% | 14% | 15.3× | 0.8% | +2.7% |
| Gillette India GILLETTE.NS | India | $2.53B | -5% | +8% | 28% | 37.1× | 14.9% | +13.0% |
| Winner Medical 300888.SZ | China | $2.53B | -6% | +4% | 11% | 19.9× | -5.2% | -2.6% |
| Cosmax 192820.KS | South Korea | $2.51B | +53% | +25% | 8% | 18.8× | n/a | n/a |
| Giant Biogene 2367.HK | Hong Kong | $2.47B | -32% | -10% | 32% | 8.6× | -10.7% | +34.9% |
| Procter & Gamble Hygiene & Health Care PGHH.NS | India | $2.37B | -30% | -2% | 24% | 27.0× | 21.2% | +7.4% |
| Amorepacific 090430.KS | South Korea | $6.01B | 0% | +10% | 9% | 24.4× | 3.6% | -0.8% |
| Softcare 2698.HK | Hong Kong | $2.20B | +5% | +25% | 25% | 14.4× | 9.1% | +20.9% |
| KOSE 4922.T | Japan | $2.16B | +16% | +4% | 5% | 29.9× | n/a | n/a |
| Blue Moon 6993.HK | Hong Kong | $2.07B | -4% | -2% | -2% | 103.3× | n/a | n/a |
Coty has 2 bonds outstanding with $1.30B face value. The agencies rate it BB+; its bonds trade like BB. Weighted yield 6.44%, a spread of 194 bp over government bonds.